228 related articles for article (PubMed ID: 30779295)
1. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
Groom KM; McCowan LM; Mackay LK; Lee AC; Gardener G; Unterscheider J; Sekar R; Dickinson JE; Muller P; Reid RA; Watson D; Welsh A; Marlow J; Walker SP; Hyett J; Morris J; Stone PR; Baker PN
BJOG; 2019 Jul; 126(8):997-1006. PubMed ID: 30779295
[TBL] [Abstract][Full Text] [Related]
2. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
[TBL] [Abstract][Full Text] [Related]
3. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.
Pels A; Kenny LC; Alfirevic Z; Baker PN; von Dadelszen P; Gluud C; Kariya CT; Mol BW; Papageorghiou AT; van Wassenaer-Leemhuis AG; Ganzevoort W; Groom KM;
BMC Pregnancy Childbirth; 2017 Dec; 17(1):440. PubMed ID: 29282009
[TBL] [Abstract][Full Text] [Related]
4. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
Sharp A; Cornforth C; Jackson R; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z;
Lancet Child Adolesc Health; 2018 Feb; 2(2):93-102. PubMed ID: 30169244
[TBL] [Abstract][Full Text] [Related]
5. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.
Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C
Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020
[TBL] [Abstract][Full Text] [Related]
6. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556
[TBL] [Abstract][Full Text] [Related]
7. Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis.
Chen J; Gong X; Chen P; Luo K; Zhang X
BMC Pregnancy Childbirth; 2016 Aug; 16():225. PubMed ID: 27528012
[TBL] [Abstract][Full Text] [Related]
8. Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Liauw J; Groom K; Ganzevoort W; Gluud C; McKinlay CJD; Sharp A; Mackay L; Kariya C; Lim K; von Dadelszen P; Limpens J; Jakobsen JC;
Syst Rev; 2021 Dec; 10(1):305. PubMed ID: 34861900
[TBL] [Abstract][Full Text] [Related]
9. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations.
von Dadelszen P; Audibert F; Bujold E; Bone JN; Sandhu A; Li J; Kariya C; Chung Y; Lee T; Au K; Skoll MA; Vidler M; Magee LA; Piedboeuf B; Baker PN; Lalji S; Lim KI
BMC Res Notes; 2022 Jul; 15(1):244. PubMed ID: 35799272
[TBL] [Abstract][Full Text] [Related]
10. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.
Ganzevoort W; Alfirevic Z; von Dadelszen P; Kenny L; Papageorghiou A; van Wassenaer-Leemhuis A; Gluud C; Mol BW; Baker PN
Syst Rev; 2014 Mar; 3():23. PubMed ID: 24618418
[TBL] [Abstract][Full Text] [Related]
11. Perinatal and Hemodynamic Evaluation of Sildenafil Citrate for Preeclampsia Treatment: A Randomized Controlled Trial.
Trapani A; Gonçalves LF; Trapani TF; Vieira S; Pires M; Pires MMS
Obstet Gynecol; 2016 Aug; 128(2):253-259. PubMed ID: 27400005
[TBL] [Abstract][Full Text] [Related]
12. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices.
Trapani A; Gonçalves LF; Trapani TF; Franco MJ; Galluzzo RN; Pires MM
Ultrasound Obstet Gynecol; 2016 Jul; 48(1):61-5. PubMed ID: 26279411
[TBL] [Abstract][Full Text] [Related]
13. A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction.
Sharp A; Jackson R; Cornforth C; Harrold J; Turner MA; Kenny L; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():109-118. PubMed ID: 31499415
[TBL] [Abstract][Full Text] [Related]
14. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial.
Shehata NAA; Ali HAA; Fahim AS; Katta MA; Hussein GK
J Matern Fetal Neonatal Med; 2020 May; 33(10):1631-1637. PubMed ID: 30345864
[No Abstract] [Full Text] [Related]
15. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial.
Maged M; Wageh A; Shams M; Elmetwally A
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):483-486. PubMed ID: 30122565
[TBL] [Abstract][Full Text] [Related]
16. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
Groom KM; David AL
Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction.
von Dadelszen P; Dwinnell S; Magee LA; Carleton BC; Gruslin A; Lee B; Lim KI; Liston RM; Miller SP; Rurak D; Sherlock RL; Skoll MA; Wareing MM; Baker PN;
BJOG; 2011 Apr; 118(5):624-8. PubMed ID: 21392225
[TBL] [Abstract][Full Text] [Related]
18. Effect of sildenafil citrate treatment in the eNOS knockout mouse model of fetal growth restriction on long-term cardiometabolic outcomes in male offspring.
Mills V; Plows JF; Zhao H; Oyston C; Vickers MH; Baker PN; Stanley JL
Pharmacol Res; 2018 Nov; 137():122-134. PubMed ID: 30292428
[TBL] [Abstract][Full Text] [Related]
19. Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.
El-Sayed MA; Saleh SA; Maher MA; Khidre AM
J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1045-1050. PubMed ID: 28345432
[TBL] [Abstract][Full Text] [Related]
20. Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study.
Pels A; Onland W; Berger RMF; van Heijst AFJ; Lopriore E; Reiss IKM; Limpens J; Gordijn SJ; Ganzevoort W
Eur J Pediatr; 2022 Apr; 181(4):1709-1718. PubMed ID: 35018508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
